Gerri Henwood
2014 - Recro Pharma
In 2014, Gerri Henwood earned a total compensation of $1.5M as President and Chief Executive Officer at Recro Pharma, a 1,106% increase compared to previous year.
Compensation breakdown
| Bonus | $205,000 |
|---|---|
| Option Awards | $993,840 |
| Salary | $285,375 |
| Other | $23,645 |
| Total | $1,507,860 |
Henwood received $993.8K in option awards, accounting for 66% of the total pay in 2014.
Henwood also received $205K in bonus, $285.4K in salary and $23.6K in other compensation.
Rankings
In 2014, Gerri Henwood's compensation ranked 5,714th out of 13,032 executives tracked by ExecPay. In other words, Henwood earned more than 56.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,714 out of 13,032 | 56th |
Division Manufacturing | 2,049 out of 4,966 | 59th |
Major group Chemicals And Allied Products | 692 out of 1,686 | 59th |
Industry group Drugs | 538 out of 1,365 | 61st |
Industry Pharmaceutical Preparations | 414 out of 1,043 | 60th |
Source: SEC filing on April 12, 2016.
Henwood's colleagues
We found two more compensation records of executives who worked with Gerri Henwood at Recro Pharma in 2014.
News
Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
March 31, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020
Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
March 20, 2019